Former Rockies outfielder could be facing a very lengthy suspension

The Colorado Rockies took a chance on utility man Jurickson Profar in March 2023, hoping to add depth after injuries sidelined outfielders Randal Grichuk and Sean Bouchard.

Profar gave Colorado a versatile switch-hitting option and eventually became the everyday left fielder, which moved high-profile signing Kris Bryant to right field.

He struggled in Colorado, batting just .236 with eight home runs and 39 RBI in 111 games. The Rockies released the outfielder in late August to make room for younger players.

Profar signed a one-year deal with the Padres in February 2024.

A prove-it contract that turned into a career year.

He earned his first All-Star selection while hitting in the middle of the order, posting a .280 average with 24 home runs and 85 RBI across 158 games.

He set career highs in hits, RBIs, home runs, and OPS (.839).

After signing a three-year, $42 million deal with the Atlanta Braves in 2025, Profar tested positive for Chorionic Gonadotropin (hCG), a hormone that stimulates testosterone production.

He was suspended without pay for half the season (80 games). When he returned, he hit .245 with 14 home runs, 43 RBI, and 56 runs scored. The suspension cost him roughly $12 million of his 2025 salary and made him ineligible for postseason play.

Fast-forward to this spring and he is reportedly facing a 162-game ban after a second positive PED test, which would cost him roughly $15 million of his 2026 salary and make him ineligible for postseason play again.

This puts another damper on the Braves' plans as they look to rebound from an injury-riddled 2025 campaign.